Modeling Type 1 Diabetes In Vitro Using Human Pluripotent Stem Cells - ScienceDirect
Clinical Trial Tests Stem Cell Therapy to Cure People with Type 1 Diabetes
Frontiers | Stem Cell-Based Clinical Trials for Diabetes Mellitus
Vertex Provides an Update on the VX-880 Clinical Trial - JDRF
Vertex snaps up diabetes stem cell rival | Nature Biotechnology
Vertex Pharmaceuticals' $950 Million Bet on Curing Type 1 Diabetes Could Have an Astronomical Payoff | The Motley Fool
Vertex – type 1 diabetes vs stem cell therapy - The Boar
Frontiers | Clinical Translational Potentials of Stem Cell-Derived Extracellular Vesicles in Type 1 Diabetes
Current progress in stem cell therapy for type 1 diabetes mellitus | Stem Cell Research & Therapy | Full Text
Vertex Releases New Data on Potential Cure for Type 1 Diabetes
Stem Cells and the Search For a Type 1 Diabetes Cure
Why stem cells may be the answer to curing Type 1 diabetes
Engineering islets from stem cells for advanced therapies of diabetes | Nature Reviews Drug Discovery
Vertex spends nearly $1bn on Semma's unproven diabetes cell tech | Evaluate
Vertex's Stem Cell-Based Type 1 Diabetes Therapy To Enter Human Trial Stage | The Healthcare Technology Report.
Stem-Cell Therapy for Type 1 Diabetes Reduced Patient's Insulin Needs by 91%
A new therapy for treating Type 1 diabetes | Harvard Stem Cell Institute (HSCI)
A Cure for Type 1 Diabetes? For One Man, It Seems to Have Worked. - The New York Times
Clinical Trial for Novel Investigational Treatment of Type 1 Diabetes Open for Enrollment in Miami | Regenerative Medicine Foundation
Applications of iPSC-derived beta cells from patients with diabetes
FDA suspends early study of Vertex stem-cell therapy for type 1 diabetes
JDRF Report: Vertex Has a New Horizon: Curing Type 1 Diabetes
